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Background: The presence of unique copy number variations (CNVs) in miscarriages suggests that their integral
genes have a role in maintaining early pregnancy. In our previous work, we identified 19 unique CNVs in ~40% of
studied euploid miscarriages, which were predominantly familial in origin. In our current work, we assessed their
relevance to miscarriage by expression analysis of 14 genes integral to CNVs in available miscarriage chorionic villi.
As familial CNVs could cause miscarriage due to imprinting effect, we investigated the allelic expression of one of
the genes (TIMP2) previously suggested to be maternally expressed in placenta and involved in placental remodelling
and embryo development.
Results: Six out of fourteen genes had detectable expression in villi and for three genes the RNA and protein expression
was altered due to maternal CNVs. These genes were integral to duplication on Xp22.2 (TRAPPC2 and OFD1) or disrupted
by a duplication mapping to 17q25.3 (TIMP2). RNA and protein expression was increased for TRAPPC2 and OFD1 and
reduced for TIMP2 in carrier miscarriages. The three genes have roles in processes important for pregnancy development
such as extracellular matrix homeostasis (TIMP2 and TRAPPC2) and cilia function (OFD1). TIMP2 allelic expression was not
affected by the CNV in miscarriages in comparison to control elective terminations.
Conclusion: We propose that functional studies of CNVs could help determine if and how the miscarriage CNVs affect
the expression of integral genes. In case of parental CNVs, assessment of the function of their integral genes in parental
reproductive tissues should be also considered in the future, especially if they affect processes relevant for pregnancy
development and support.
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Genetic factors, such as single gene defects and chromo-
somal abnormalities, are a common cause of miscarriage
[1-3]. Their identification is important for informed re-
productive decisions and counselling and is the key goal
of reproductive genetics [4,5]. The detection of chromo-
somal abnormalities has been recently revolutionized
with the development of chromosome microarray ana-
lysis (CMA) which facilitates the detection of large scale
and subtle chromosomal microdeletions and microdupli-
cations (DNA copy number variants or CNVs). CMA is* Correspondence: eseparovic@cw.bc.ca
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tissues and thus minimizes the negative impact of tissue
culture artefacts and failure associated with traditional
cytogenetic analysis of miscarriages.
Due to its many benefits, including improved reso-
lution and diagnostic yield, CMA is now considered a
first line test for subjects with postnatal developmental
delay and congenital abnormalities [6,7]. It identifies
clinically relevant CNVs in 10-15% of chromosomally
normal cases, with the majority of CNVs undetectable
by routine karyotyping. In contrast, array studies of mis-
carriages are still rare, and no more than 3000 cases
worldwide were reported [3]. Most of the miscarriage
cases (2392) were described in the recent publication by
Levy et al. [8], which reported putatively causative CNVs
in 1.6% of chromosomally normal cases. These CNVs
were defined as >5 Mb or overlapping with criticalis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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duplication syndromes.
Interestingly, the majority of CNVs identified so far in
miscarriages with a normal karyotype were familial in
origin. CNVs inherited from normal parents are gener-
ally considered less likely to be causative of an ab-
normal phenotype, however, they can be pathogenic
if they i) uncover a mutation within the intact allele of
the developmental gene in the conceptus, ii) contain
genes with variable expressivity or penetrance iii) involve
imprinting (parent of origin dependent) genes. In
addition, parental CNVs could still lead to miscarriage if
they affect genes required for normal parental reproduct-
ive function, including, for example, genes required for
placenta function, maternal preparation for and mainten-
ance of pregnancy and genomic stability of the sperm.
These processes are essential for successful pregnancy
outcome [9], but may not necessarily impair parents’
overall health status and can demonstrate pathogenic
characteristics only at the time of pregnancy. Recently,
Nagirnaja et al. [10], suggested that a CNV from 5p13.3
chromosomal region is enriched in women with recur-
rent pregnancy loss (RPL) in comparison to fertile
controls and could represent a risk factor for preg-
nancy complications, as it contains genes predominantly
expressed in placenta.
We have recently performed CMA analysis of miscar-
riages from couples with RPL and sporadic miscarriages
with embryoscopy findings [11,12]. Unique CNVs not
reported in Database of Genomic Variants were noted
in ~40% of miscarriages and were predominantly paren-
tal in origin, making their interpretation more challen-
ging. In order to further investigate the potential role of
these CNVs in miscarriage we performed functional ana-
lysis (RNA and protein expression) of genes integral to
miscarriage CNVs, using chorionic villi from miscar-
riages from 6 families with RPL, reported in our previ-
ous work. Our study shows changes in RNA/protein
expression for 3/14 tested genes from maternal CNVs,
which could be of relevance for miscarriage due to their
role in processes important for growth of the conceptus
and/or maternal preparation for and support of preg-
nancy. Functional studies of miscarriage CNVs could
therefore help identify miscarriage candidate genes, but
should be accompanied with functional studies of CNVs
in reproductive tissues of carrier parents.
Results
Expression of genes integral to CNVs in miscarriage
cell cultures
Three genes, OFD1, TRAPPC2 and TIMP2 out of 14 se-
lected for expression analysis had altered mRNA and
protein expression in cultured miscarriage chorionic villi
cells (Table 1 and Figures 1 and 2). For NDUFAF2, CHSY3and PRMT3 (Table 1) the expression in control pregnan-
cies and miscarriages with CNVs was comparable. The
remaining genes assayed had either very low or no expres-
sion in cultured chorionic villi from controls (PARK, LIPC,
CTNNA3, EGFL6, GPM6B, RAB9A, POU6F2 and C7orf10)
and were not assessed in miscarriages.
OFD1 and TRAPPC2 are integral to a CNV on Xp22.2
(duplication with breakpoints from 13415099–13745233)
identified by Agilent 105 k array (Figure One in Rajcan-
Separovic et al. [12]) in female 09–1 who had 6 mis-
carriages (current paper, Additional file 1: Table S1). Two of
her 6 miscarriages had array analysis: male miscarriage
09-3A had a normal array result, while female miscarriage
09-3B inherited the maternal Xp22.2 CNV. These two mis-
carriages were available for functional analysis. Increased
RNA and protein expression for OFD1 and TRAPPC2 was
detected in 09-3B (Figure 1), while the remainder of the
genes from the Xp22.2 CNV (EGFL6, GPM6B, and
RAB9A) had low or undetectable expression in control ET
cell cultures and were not evaluated in 09-3B (Table 1).
Random chromosome X inactivation was identified in
09-3B, while the mother’s chromosome X inactivation
status was uninformative [12].
The CNV disrupting the TIMP2 gene mapped to 17q25.3
(duplication with breakpoints from 74,381,287 -74,466,887)
and was detected in female 6–1 and in 4/5 available
miscarriages, as reported previously (Figure Two in
Rajcan-Separovic et al. [12]). Cell cultures from chorionic
villi were available from four miscarriages (06-3A, C, D
which contained the CNV and 06-3E which did not). The
three miscarriages with the TIMP2 CNV (06-3A, C and D)
showed a ~50% decrease in mRNA and protein expression
in comparison to four control elective terminations (ET 15,
17, 18 and 20). A ~2-fold increase of TIMP2 mRNA and
protein was noted in the fourth miscarriage (06-3E), which
did not carry the TIMP2 CNV (Figure 2).
TIMP2 Allelic expression analysis
Based on previous reports suggesting preferential mater-
nal expression of TIMP2 in placenta [13], we tested the
parent-of-origin specific expression of TIMP2 in control
ET and in miscarriages from female 06–1 to determine if
the CNV affected the TIMP2 allelic expression. Monoal-
lelic expression of the maternal allele was detected in 2
of 3 informative miscarriages (06-3C with and 06-3E
without the CNV, Figure 3) while a close to biallelic
expression (~60%) was noted in the third miscarriage
(06-3D) which was trisomic for chromosome 16 and
contained the TIMP2 CNV. Monoallelic expression of
the maternal allele was also noted in two of the seven in-
formative ET samples heterozygous for the polymorphic
rs2277698 G/A SNP in exon 3 (out of 35 genotyped).
The cells from the remaining 5 control and informative
ETs had biparental expression.
Table 1 CNV gene analysis




Gene picked for expression
(type of CNV abnormality)
mRNA expression in control
elective terminations/miscarriage





03-3A 6q26 162126633-162271770 145 loss-pat PARK2 (loss involves part of
exon and intron)
N/not attempted




17q25.3 74381287-74466887 86 gain-mat TIMP2 (gain involves exon1,2) yes/decrease in CNV carriers decreased
06-3E 15q22.1 56487120-56562873 76 loss-pat LIPC (loss of exon1) N/not attempted
07-3A 10q21.3 67992425-68064617 72 loss-mat CTNNA3 (loss involves exon11) N/not attempted
09-3B (not in 3A) Xp22.2 13415099-13745233 33 gain-mat EGFL6 (complete gain) N/not attempted
GPM6B (almost complete gain) N/not attempted
OFD1 (complete gain) yes/increase in CNV carrier increased in CNV
carrier
RAB9A (complete gain) N/not attempted
TRAPPC2 (complete gain) yes/increase in CNV carrier increased in CNV
carrier
10-3A 5q23.3 129388119-129441487 53 loss-pat CHSY3 (CSS3) (loss involes intron) yes/no difference between CNV
carrier and controls
11p15.1 20442396-20559837 117 Gain-pat PRMT3 (gain involves exon9-11) yes/no difference between CNV
carrier and controls
7p14.1 39470588-39647671 177 Gain-mat POU6F2 (gain involves last exon) N/not attempted
C7orf10 (complete gain) N/not attempted












Figure 1 mRNA and protein expression of OFD1 and TRAPPC2 in primary culture of human chorionic villi. ET 15, 17, 18 and 20 indicate
control samples from the cell cultures of elective terminations (n = 4). 09-3A and B indicate miscarriages from female 09–1. mRNA (i) and protein
(ii) values for (A) OFD1 and (B) TRAPPC2 expression were normalized to the corresponding ß-actin mRNA levels. The results derived from at least
three repeats of each sample and the mean level of each sample is represented in the scatter graph. The difference between the four control
samples (as a group) and the two CNV carrier miscarriages, as two groups, has been evaluated by Student t-test (*, p < 0.05).
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In this study we explored further the miscarriage CNVs
we identified in our previous work by testing the expres-
sion levels of their integral genes in available miscarriage
tissues with CNVs. Three genes integral to maternal
CNVs had altered expression in miscarriages consistent
with genomic alternation caused by the CNV.
TRAPPC2 and OFD1 had increased RNA and protein
expression in miscarriage 9-3B with a gain of Xp22.2.
TRAPPC2 has a role in procollagen transportation [14]
while OFD1 regulates cilia function [15]. Collagens are
the main components of extracellular matrix (ECM) and
provide structural support for the tissues, but also
play important roles in cell growth, differentiation,
adhesion, and migration [16,17]. The dysfunction of
OFD1, through abnormal ciliogenesis, results in defects in
sonic hedgehog (Shh) and canonical Wnt signaling path-
ways [15,18-20] which are linked to abnormal implant-
ation and embryonic development [21-23]. Although the
mis-expression of TRAPPC2 and OFD1 could potentially
explain miscarriage 9-3B, the Xp22.2 CNV was notpresent in miscarriage 09-3A, and therefore cannot be as-
sociated with all the pregnancy losses of female 09–1. In-
stead, the unifying cause of her miscarriages could be the
effect of the CNV on maternal OFD1 and TRAPPC2 gene
expression, particularly because of the reports of abnormal
uterine collagen content resulting in pregnancy loss
[24,25]. It would be of interest the explore the expression
of these genes in the decidua of female 9–1. Unfortunately
this tissue was not available for analysis.
TIMP2 is the third gene that showed altered expres-
sion in miscarriages and is known to inhibit matrix
metaloproteases (MMPs), which degrade extra cellular
matrix (ECM), and have a critical role in tissue remodel-
ling and angiogenesis in placenta/endometrium [26-29].
Expression of TIMP2 was reduced in miscarriages with
the CNV, possibly because the CNV (duplication) disrupts
the 5′ end of the gene and causes structural alternations
in the genomic region of TIMP2. It has been previously
observed that the genomic position of regulatory elements
in the TIMP2 promoter (AP-1) affects the gene expression
[30]. However, the CNV appears not to be the sole cause
Figure 2 mRNA and protein expression of TIMP2 in primary culture of human chorionic villi. ET15, 17, 18 and 20 indicate control cell
cultures from elective terminations (n = 4). 06-3A, C, D and E indicate miscarriages of the female 06–1 (n = 4). (A) mRNA and (B) protein values for
TIMP2 expression were normalized to the corresponding ß-actin mRNA levels. The results derived from at least three repeats of each sample and
the mean level of each sample is represented in the scatter graph. The difference between the four control samples and the three CNV carrier
miscarriages, as two groups, has been evaluated by student t-test (*, p < 0.05).
Wen et al. Molecular Cytogenetics  (2015) 8:6 Page 5 of 9of recurrent miscarriage in this family as TIMP2 expres-
sion was also altered (increased) in the miscarriage with-
out the CNV. It is conceivable that, due to the CNV, the
expression of TIMP2 is also abnormal (reduced) in the
endometrium/decidua of female 6–1 and could impair
pregnancy development. This is of interest considering
that decidual TIMP2 has a role in regulating trophoblast
invasion by modulating trophoblast MMP and TIMP2 ex-
pression [31], and in particular inhibiting trophoblast
TIMP2 expression. In keeping with the possibility of the
effect of the maternal and/or pregnancy CNV on TIMP2
function are the pathology findings for six out of ten mis-
carriages from female 6–1 which demonstrated morpho-
logic abnormalities of the maternal vasculature (intimal
hyperplasia of maternal vessels) and/or placenta (perivil-
lous fibrin deposits) [12] (Additional file 1: Table S1).
Familial CNVs are frequently hypothesised to cause an
adverse outcome of the pregnancy if they contain ordisrupt imprinting genes. Previous reports suggested
that TIMP2 is an imprinted gene with preferential ma-
ternal expression in placenta. This was based on obser-
vations of reduced expression in placenta from complete
moles [13], and overexpression of the maternal copy in a
mouse model of RPL [32]. We were therefore interested
in finding out if the maternal CNV, disrupting the
TIMP2 gene, affects its allelic expression in miscarriages
that carry the CNV. Our parent of origin expression
analysis demonstrated biallelic expression in most cases
including one miscarriage with the CNV. However, it ap-
pears that the regulation of TIMP2 allelic expression is
complex, as it was preferentially maternal in 2/3 miscar-
riages and 2/7 ETs. It is possible that the allelic expres-
sion of this gene is affected by the degree of clonality
after placental cell culture, the ratio of methylation of
CpG islands (Chernov, et al. [33]), or additional genetic
polymorphisms affecting gene expression on one or
Figure 3 Allelic expression of TIMP2 gene. (A) schematic diagram of the structure of the TIMP2 gene region, including its 5 exons (grey bars)
and transcription start site (TSS). Important genomic features, including the copy number variation (CNV) identified in the recurrent miscarriage
family, and a polymorphic coding single nucleotide polymorphism (SNP) used to assess TIMP2 allelic expression have been labelled. (B) Percentage
gene expression of the major allele for rs2277698 in exon 3 of TIMP2 gene in informative chorionic villi from 1st trimester elective terminations (ET)
and miscarriages from recurrent miscarriage family 06. Miscarriage 06-3C and 06-3D had the CNV while miscarriage 06-3E did not.
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marks at the TIMP2 gene promoter region(s) in relation
to expression is needed to elucidate whether this gene is
indeed imprinted and which modifications are important
for regulation of gene expression.Conclusion
Overall, our findings underscore the need for additional
functional characterization of miscarriage CNVs to
develop an understanding of the effect of their integral
genes on pregnancy development. These studies can be
challenging due to lack of miscarriage cell cultures or
RNA/protein for functional studies in miscarriages and
lack of parental reproductive tissues in cases with
parental CNVs. Collection of reproductive tissues (e.g.
maternal decidua) for functional analysis would be
desirable in future miscarriage CNV analysis. As more
miscarriage associated CNVs and genes are identified,
their individual and collective role in miscarriage will
become more apparent.Methods
Subjects
Control pregnancy and miscarriage tissues
Control chorionic villus samples were obtained from
first trimester elective terminations (ET) of pregnancy
for social reasons by dilation and curettage (6–12 weeks
of gestation). The control ET had no evidence of aneu-
ploidy as determined by multiplex ligation dependent
probe amplification (MLPA) [34]. Four ET tissues were
used for tissue culture, as previously described [35].Thirty five uncultured ET tissues were assessed for
allelic expression analysis of TIMP2 gene (see below).
Chorionic villus cell cultures of 10 miscarriages from 6
families (03,05,06,07,09 and 10 as described in Table 1 in
the current paper and in Rajcan-Separovic et al. [12])
were available for RNA and protein expression analysis.
Culture conditions were as for the ET tissues [35].
Maternal contamination has been ruled out in all ET
and miscarriage cultures by examining microsatellite
markers, using standard protocols [12,36]. The use of
parental blood samples, control and miscarriage tissues
was approved by the Committee for Ethical Review
of Research involving Human Subjects, University of
British Columbia and Institutional Review Board of the
University of Chicago. All subjects gave written informed
consent for these studies.
Expression analysis
RNA, DNA and protein extraction
Total RNA, DNA and protein were extracted from the
chorionic villus (CV) cell cultures simultaneously using
commercially available kits (AllPrep DNA/RNA Mini
kit, Qiagen) according to the manufacturer’s instruc-
tions. The purity and concentration of total RNA, DNA
and protein present in each of these extracts were quanti-
fied using a NanoDrop 1000 Spectrophotometer (Thermo
Scientific, Wilmington, USA).
For allelic expression analysis, RNA and DNA were
extracted from ET tissue stored in RNA later. Genomic
DNA (gDNA) was used to obtain fetal genotype and
informative (heterozygous) samples were used for the
allelic expression analysis.
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Aliquots of the total RNA extracts (~500 ng) prepared
from the CV cell cultures were subsequently reverse-
transcribed into cDNA using GeneAmp Gold RNA PCR
Core Kit (Applied Biosystems, Melbourne, Australia).
High Capacity cDNA Reverse Transcription Kit (Applied
Biosystems, Melbourne, Australia) was used to generate
cDNA from 35 ET tissues for TIMP2 allelic expression
analysis.
Real-time quantitative (q)PCR
RNA expression analysis was performed in cultured
chorionic villi from miscarriages with CNVs and four
ETs. Fourteen genes integral to the miscarriage CNVs
were selected, and bioinformatics tools and publicly
available human genome databases (Ensemble Genome
Browser, UCSC) are used to select appropriate primers.
The genes for expression analysis were selected based on
the availability of cells/RNA/protein from miscarriages
that contained their copy number change and included:
PARK2, NDUFAF2, TIMP2, LIPC, CTNNA3, EGFL6,
GPM6B, OFD1, RAB9A, TRAPPC2, CHSY3, PRMT3,
POU6F2, and C7orf10 (Table 1). The nucleotide se-
quences for primers specific for the 14 genes or the
housekeeping gene β-actin were designed using Primer
Express software (Perkin-Elmer Applied Biosystems)
and purchased from Integrated DNA Technologies
(IDT). Primer sequences for tested regions are listed
in Additional file 1: Table S2. The first-strand cDNA
generated from the chorionic villi cells served as a tem-
plate for qRT-PCR using the ABI PRISM 7300 Sequence
Detection System (Perkin-Elmer Applied Biosystems)
equipped with a 96-well optical reaction plate for primers
specific for 14 selected genes and the housekeeping gene,
β-actin. Real-time qPCR was performed as previously de-
scribed [37].
Western blot analysis
We detected changes in RNA expression for 3 genes in
miscarriages: OFD1 and TRAPPC2 from Xp22 CNV
(present in female 09–1 and one out of two miscar-
riages) and TIMP2 from 17q25 CNV (present in female
6–1 and 4/5 miscarriages). Protein expression analysis
for these genes was performed using polyclonal anti-
bodies directed against human OFD1 (Abcam, No.
ab97861, ON, Canada), TRAPPC2 (generous gift from
Dr De Matteis, Italy) and TIMP2 (NovusBiologicals, No.
NB100-92000, Littleton, US). To standardize the
amounts of protein loaded into each lane, the blots were
reprobed with a monoclonal antibody directed against
human β-actin (Novus Biologicals, Littleton, US). The
ECL Western Blotting system was used to detect the
amount of each antibody bound to antigen and the
resultant photographic films were analyzed by UVdensitometry (GE Healthcare Life Sciences, Pittsburgh,
USA). The absorbance values obtained for OFD1,
TRAPPC2 or TIMP2 were then normalized relative to the
corresponding β-actin absorbance value. The average of
OFD1, TRAPPC2 and TIMP2 protein expression were ob-
tained from 3 independent replicates for each miscarriage
and ET control samples.
Allelic expression analysis of TIMP2 gene
We assessed the effect of the CNV on allelic expression
in miscarriages from female 6–1 rather than methylation
since the TIMP2 promoter is unmethylated in cervix
and blood [38], human term placenta (unpublished data)
and mouse placenta throughout pregnancy [39]. Three
heterozygous SNPs were identified within the exons of the
TIMP2 gene using UCSC Genome Browser: rs7503726
and rs2277698 in the 5′UTR and rs2277698 within exon 3.
Genotyping assays were designed for all three SNPs, using
the PSQ Assay Design Software; with successful targeted
amplification for only the rs2277698 G/A SNP in
exon 3 (heterozygosity = 0.241 ± 0.250) (Additional file 1:
Table S3). Genotyping was done on the Pyromark MD
machine using the PyroGold SQA reagent kit (Qiagen,
Hilden, Germany), using gDNA from placenta to obtain
fetal genotypes. Genotyping was performed on DNA from
35 ET samples and 5 miscarriages from female 6–1 with
RPL, 4/5 carried the TIMP2 CNV. 7/35 ET and 3/5 tested
miscarriages were informative (heterozygous). Parental ori-
gin of the rs2277698 alleles in ET and miscarriage samples
was determined by assessing maternal genotypes in DNA
extracted from the placental decidua or blood. The sequen-
cing primer used for the gDNA assay (Additional file 1:
Table S3), was then used to assess whether there was allelic
bias in expression of TIMP2 in the cDNA, after cDNA-
specific amplification. The relative percentage of expressed
alleles was obtained using the allelic quantification setting
on the Pyromark MD software, and averaging of two inde-
pendent replicates for each sample.
Statistical analysis
All statistical tests were performed using the VassarStats:
Statistical Computation Web Site (Vassar College,
Poughkeepsie, USA), R Statistical Software 2.12.0 (The
R Project for Statistical Computing, Auckland, New
Zealand) or GraphPad Prism 4 computer software
(GraphPad, San Diego, CA). Student’s t-test was used
to determine significant differences in transcript levels
between the four miscarriages from family 6 with avail-
able cultures (3 that carry the TIMP2 CNV and one with-
out it) and four control ETs. p < 0.05 was considered
significant. Significance between the variances of the two
groups was determined using F- test.
The absorbance values obtained from the real-time
qPCR products and the photograph generated by
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using GraphPad Prism 4 computer software (GraphPad,
San Diego, CA). Statistical significance between the ab-
sorbance values were assessed by the analysis of variance
(ANOVA), with p < 0.05 considered significant. Compari-
son of the means between patients and controls were de-
termined using Dunnett’s test. The results are presented
as the mean ± S.E.M. from at least three independent
experiments.
Additional file
Additional file 1: Table S1. Pathology description of the recurrent
miscarriages with familial CNV. Table S2. Primer sequences for Real-time
qPCR. Table S3. Primers used to assess allelic expression of TIMP2.
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